Saturday, May 19, 2012

Eisai and Pfizer Inc’s Drug for Alzheimer’s Commercial Too Misleading Says FDA

Eisai and Pfizer Inc’s Drug for Alzheimer’s Commercial Too Misleading Says FDA

February 20, 2010 by · Leave a Comment 

Eisai and Pfizer Inc’s drug for Azheimer’s commercial too misleading says FDA. U.S. regulators released a letter today stating  two ads for the Alzheimer drug, Aricept, are misleading because they suggest the therapy offers a drastic improvement not supported by available data. The FDA stated in a letter Feb. 3, that the ads depicted patients whose behavior [...]

Share